Clinical Trial Update: An Exploratory Study of RO4929097 in Patients With Recurrent or Refractory Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

The document reports the completion of a Phase 2 exploratory trial evaluating RO4929097 in patients with recurrent or refractory non-squamous non-small cell lun…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• RO4929097 (RO4929097)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Non-Squamous Non-Small Cell Lung Cancer | Phase 2 | Status: COMPLETED